Equipping Patients Using Interventions for Pain and Depression
Part of paid clinical trials in Indianapolis, Indiana.
- Sponsor
- Indiana University
- Study ID
- NCT06500780
- Status
- Recruiting
Conditions
- Chronic Pain
- Depression
- Health Equity
- Musculoskeletal Pain
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Coaching and Decision Aid — BEHAVIORALFour (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
Study Details
This project is part of the NIH Helping to End Addiction Long-term (HEAL) initiative (https://heal.nih.gov/). This randomized controlled trial (RCT) is phase 2 of a two-phase, 5-year project with the overarching goal of testing a decision aid (DA)/coaching intervention, tailored to Black patients with comorbid chronic pain and depression, to encourage use of and adherence to nonpharmacological pain treatments (NPTs). This 2-arm trial will randomize 304 patients with comorbid chronic musculoskeletal pain and depression in primary care from an urban safety-net health system (Eskenazi). After the baseline assessment, patients randomized to the intervention will be asked to participate in 4 coaching sessions over approximately 12 weeks. Sessions will use Motivational Interviewing principles to foster openness to NPTs and self-efficacy by helping patients identify their goals and priorities, understand their NPT options, prepare them to discuss and choose options with their primary care providers (PCPs), and reinforce these choices to foster maintenance of these changes. DA contents will be integrated into these sessions, which will facilitate discussion of these options with their PCP. The first 3 sessions take place prior to the patient's next scheduled PCP visit; the final session occurs after this visit. Assessments will be conducted at baseline, 3 months (i.e., after completing the final coaching session), and 6 months. Patients randomized to the wait-list control group will receive usual care (in addition to study assessments at baseline, 3 months, and 6 months). After completing the final assessment, they will then be given the DA and offered a 20-minute coaching session to walk them through it.
Key Dates
- Start date
- Aug 13, 2024
- Status verified
- Jun 2026
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 304 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Coaching and Decision AidIntervention group (Individual coaching sessions and Decision Aid)
- No Intervention: ControlWait-list control group
Primary Outcome Measure
Change from Baseline Brief Pain Inventory (BPI) Interference Scale at 3 months [ Time Frame: 3 months ]
Central Contacts
- Research Specialist317-274-9402
- Jennifer Garabrant317-278-2510
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Eskenazi Health Primary Care | Indianapolis | Indiana | 46254 | Adam T Hirsh, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Indianapolis, IN
Related Studies
- Patient Retrospective Outcomes (PRO)Recruiting · Boston Scientific Corporation · Lake Havasu City, Arizona
- Long-Term Real-World Outcomes Study on Patients Implanted With a NeurostimulatorRecruiting · Abbott Medical Devices · Phoenix, Arizona
- A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.PHASE3 · Recruiting · AbbVie · Bentonville, Arkansas
- Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic PancreatitisRecruiting · University of Pittsburgh · Indianapolis, Indiana